Skip to main content
OpenTrials
Completed

NCT Number: NCT06623019

Study of the Validity and Reliability of Two Digital Dynamometers in Older People

It is a cross-sectional, randomized, and single-center study with a duration of 6 months. The study will follow the STROBE guidelines for cross-sectional studies and CONSORT 2024. The main objective is to evaluate the validity and reliability of two devices in measuring grip strength and muscle fatigability in community-dwelling older adults.The study will include community-dwelling older adults of both sexes over 60 years of age.

Completed

Looking for future studies?

Notify Me

Key information

Age range

65 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Salamanca

Salamanca, 37007, Spain

About this study

Design: It is a cross-sectional, randomized, and single-center study with a duration of 6 months. The study will follow the STROBE guidelines for cross-sectional studies and CONSORT 2024. The main objective is to evaluate the validity and reliability of the Device 1 and Device 2 devices in measuring grip strength and muscle fatigability in community-dwelling older adults.

It will be carried out in two stages: In a first moment the criterion and interobserver validity will be assessed and in a second moment the intraobserver validity. Participants will be randomly assigned to one of the 6 arms to follow different orders of the devices (Device 1, Device 2 or Jamar).

Population: community-dwelling older adults of both sexes over 60 years of age.

Procedures: The investigators will schedule each participant for the initial assessment day. Using a table of random numbers, they will be assigned one of the arms. All participants have previously read, signed and given their written informed consent. An interview will be conducted in which age, sex and medication will be collected; an anthropometric and functional assessment will be performed. The functional tests include the 30-second squat test and grip strength tests using the Jamar, Device 1 and Device 2. Three repetitions will be performed with each device, allowing 30 seconds between repetitions and 3 to 5 minutes between devices. After 20 minutes the test will be repeated again on the devices for interobserver validation. 5 to 10 days later, tester 1 will repeat the grip test with the same effort to assess intraobserver reliability.

Sample size: Similar studies validating grip strength devices compared to the Jamar showed an excellent correlation (ICC > 0.90). With an estimated ICC of 0.90 ± 0.05 and an alpha risk of 5%, 348 participants are required for the training study.

Variables: Sociodemographic (age, sex, hand dominance, number of medication types), anthropometric (height, weight, BMI and SMI), strength and fatigability (total number of repetitions in 30sCS, maximal grip strength (HGS), fatigue resistance (FR) and grip work (GW)) and device preference.

Statistical analysis: Maximal strength and fatigability will be analyzed by means of means, standard deviations and statistical tests. Concordance between devices will be assessed using the Kappa coefficient and the Bland-Altman concordance index. ROC curves will be used to determine sensitivity and specificity, and data will be analyzed by gender. Results will be considered statistically significant if p < 0.05, and IBM SPSS Statistics v28.0 will be used for analysis.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Community-dwelling older adults of both sexes over 60 years of age.

Exclusion criteria

  • Those who do not understand the orders given to them by the researcher or present an obvious advanced state of dementia.
  • Those people who have amputation in one of the two upper limbs or who cannot perform manual grasping for any reason.
  • Those who have had an episode of pain in one of the hands during the week prior to the measurement.
  • Those who, due to any illness, prevent or contraindicate maximum resistance exercises.
  • Any other cause that the research team assesses that may affect the results.

Treatment and study plan

Validation and reliability

Diagnostic Test

As this is a cross-sectional validation study, there is no intervention.

Primary outcomes

  1. 2. Hand grip test

    Time frame: 2 weeks

    Measurement of hand grip strength using a hand-held dynamometer. Values shall be recorded with all three devices.

Secondary outcomes

  1. Body Mass Index (BMI)

    Time frame: 2 weeks

    Is a mathematical ratio that associates the mass and the size of an individual BMI = weight / height ^2

  2. 4. Appendicular Skeletal Muscle mass Index (SMI)

    Time frame: 2 weeks

    Is a mathematical ratio that associates the muscle mass and the size of an individual SMI = appendicular muscle mass / height ^2

  3. 30 seconds chair stand test (30sCS)

    Time frame: 2 weeks

    Test that measures the number of times you perform the maximum number of squats on a chair in 30 seconds. The more squats the better functionally.

  4. Fatigue resistance (FR)

    Time frame: 2 weeks

    Time taken to lose 50% of the maximum recorded grip strength.

  5. Grip work (GW)

    Time frame: 2 weeks

    Value resulting from multiplying the maximum grip force by the fatigue strength by 0,75. It is measured in watts.

Sponsors and collaborators

Lead sponsor

University of Salamanca

Other

Registry information

Acronym: SOVARDDIOP

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Oct 2, 2024
Registry last updated
Dec 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.